L3VLUP
ProSign in

SIBN · LLY in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

SIBNLLY
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • SIBN
  • LLY
0204060202120222023202420252026
Holders and value by quarter
QuarterSIBNLLY
Q3 2020none listed holders, n.a.33 holders, $14.1bn
Q4 20202 holders, $18m29 holders, $17.3bn
Q1 20212 holders, $27m24 holders, $23.0bn
Q2 20212 holders, $27m24 holders, $27.8bn
Q3 20212 holders, $26m31 holders, $29.9bn
Q4 20211 holders, $27m31 holders, $34.7bn
Q1 20223 holders, $47m24 holders, $35.3bn
Q2 20222 holders, $34m33 holders, $42.7bn
Q3 20223 holders, $48m31 holders, $43.4bn
Q4 20223 holders, $29m31 holders, $46.6bn
Q1 20231 holders, $16m33 holders, $44.3bn
Q2 20231 holders, $16m37 holders, $59.6bn
Q3 20231 holders, $12m44 holders, $67.6bn
Q4 20231 holders, $12m45 holders, $73.6bn
Q1 20241 holders, $9.6m41 holders, $95.3bn
Q2 20241 holders, $7.6m43 holders, $110bn
Q3 20241 holders, $8.2m45 holders, $107bn
Q4 20242 holders, $11m46 holders, $93.9bn
Q1 20252 holders, $13m42 holders, $98.4bn
Q2 20253 holders, $19m43 holders, $93.2bn
Q3 20252 holders, $8.1m39 holders, $86.7bn
Q4 20252 holders, $12m41 holders, $123bn
Q1 20261 holders, $8.1m39 holders, $106bn
Q2 20261 holders, $13m44 holders, $132bn
SIBN

Si Bone Inc

Holders
1
Reported value
$7.6m
Buyers
0
Sellers
0

Breadth 0 among 94 comparable managers.

Medical devices and instrumentsHealthcare: biopharma and medtech · L3VLUPSurgical, medical and electromedical devices
LLY

Eli Lilly & Co

Holders
43
Reported value
$110bn
Buyers
29
Sellers
17

Breadth +12 among 94 comparable managers.

Pharmaceuticals and biotechnologyHealthcare: biopharma and medtech · L3VLUPPharmaceutical preparations

Who holds both, Q2 2024

Among the 43 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Only SIBN (0)

None.

Only LLY (42)

Acadian Asset Management LLC, AllianceBernstein LP, AQR Capital Management LLC, Arrowstreet Capital LP, Artisan Partners LP, Balyasny Asset Management LLC, Bridgewater Associates LP, Capital Research Global Investors, Capital World Investors, Caxton Associates LLP, Citadel Advisors LLC, Coatue Management LLC, D. E. Shaw & Co., Dodge & Cox, ExodusPoint Capital Management LP, Fidelity (FMR LLC), GAMCO Investors Inc, Hudson Bay Capital Management LP, Invesco Ltd, Jane Street Group LLC, Janus Henderson Group Ltd, Man Group PLC, Marshall Wace LLP, MFS Investment Management, Millennium Management LLC, and 17 more

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →